Remi Goupil

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Aldosterone in Hypertension: From Secondary Cause to Central Driver.

Aldosterone in Hypertension: From Secondary Cause to Central Driver.

Journal: The Canadian journal of cardiology

Published: June 16, 2026

Clarifying the Epidemiologic Implications of the 2025 Hypertension Canada Guideline.

Clarifying the Epidemiologic Implications of the 2025 Hypertension Canada Guideline.

Journal: The Canadian journal of cardiology

Published: June 08, 2026

A Pilot Randomised Controlled Trial of a Targeted Dietary Approach to Potassium Management in Hemodialysis: A Clinical Research Protocol for the Evidence for Optimal Potassium Intake in Hemodialysis (EvoKe-HD) Study.

A Pilot Randomised Controlled Trial of a Targeted Dietary Approach to Potassium Management in Hemodialysis: A Clinical Research Protocol for the Evidence for Optimal Potassium Intake in Hemodialysis (EvoKe-HD) Study.

Journal: Canadian journal of kidney health and disease

Published: May 26, 2026

Cardiovascular risk is increased in patients with Paget's disease of bone: Insights from the CARTaGENE cohort.

Cardiovascular risk is increased in patients with Paget's disease of bone: Insights from the CARTaGENE cohort.

Journal: Bone

Published: April 06, 2026

Response to letters about Hypertension Canada guideline.

Response to letters about Hypertension Canada guideline.

Journal: Canadian family physician Medecin de famille canadien

Published: March 17, 2026

Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study.

Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study.

Journal: The Canadian journal of cardiology

Published: February 12, 2026

Renin-guided therapy with mineralocorticoid receptor antagonists in primary aldosteronism: feasibility study (RETAME-PA) - a clinical research protocol for a randomised controlled trial.

Renin-guided therapy with mineralocorticoid receptor antagonists in primary aldosteronism: feasibility study (RETAME-PA) - a clinical research protocol for a randomised controlled trial.

Journal: BMJ open

Published: December 19, 2025

Revisiting Unattended Versus Attended Automated Office Blood Pressure Measurements: A Systematic Review and Meta-Analysis.

Revisiting Unattended Versus Attended Automated Office Blood Pressure Measurements: A Systematic Review and Meta-Analysis.

Journal: Journal of the American Heart Association

Published: December 11, 2025

Hospitalization Risk in the Integrated Home Dialysis Model: Analysis of the Canadian Organ Replacement Register.

Hospitalization Risk in the Integrated Home Dialysis Model: Analysis of the Canadian Organ Replacement Register.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 09, 2025

Subclinical Primary Aldosteronism and eGFR Decline Over Time.

Subclinical Primary Aldosteronism and eGFR Decline Over Time.

Journal: Journal of the American Society of Nephrology : JASN

Published: October 13, 2025

Implementing the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: How to Translate Team-Based Care of Hypertension to the Real World.

Implementing the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: How to Translate Team-Based Care of Hypertension to the Real World.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: September 17, 2025

Assessing vascular health by measuring arterial stiffness in response to hemodynamic load.

Assessing vascular health by measuring arterial stiffness in response to hemodynamic load.

Journal: Journal of hypertension

Published: August 18, 2025

Showing 1-12 of 86

Last Updated: 09/26/2026